QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Estrella Immunopharma (ESLAW) Competitors

$0.04
0.00 (0.00%)
(As of 03/4/2024 ET)

ESLAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Estrella Immunopharma stock or one of its competitors? The main competitors of Estrella Immunopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Estrella Immunopharma vs.

Estrella Immunopharma (NASDAQ:ESLAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, community ranking, institutional ownership, analyst recommendations, dividends and risk.

In the previous week, 180 Life Sciences had 2 more articles in the media than Estrella Immunopharma. MarketBeat recorded 3 mentions for 180 Life Sciences and 1 mentions for Estrella Immunopharma. Estrella Immunopharma's average media sentiment score of 1.87 beat 180 Life Sciences' score of 0.30 indicating that Estrella Immunopharma is being referred to more favorably in the media.

Company Overall Sentiment
Estrella Immunopharma Very Positive
180 Life Sciences Neutral

Estrella Immunopharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Estrella ImmunopharmaN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estrella ImmunopharmaN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Estrella Immunopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
Estrella ImmunopharmaN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Estrella Immunopharma and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.


Get Estrella Immunopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ESLAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESLAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESLAW vs. The Competition

MetricEstrella ImmunopharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$306.47M$4.90B$7.55B
Dividend YieldN/A3.41%5.37%3.87%
P/E RatioN/A206.88265.8118.62
Price / SalesN/A25,232.502,952.3377.10
Price / CashN/A13.6132.7028.77
Price / BookN/A5.054.474.46
Net IncomeN/A-$15.28M$112.57M$212.48M
7 Day PerformanceN/A-0.10%4.13%2.05%
1 Month PerformanceN/A4.12%12.43%6.22%
1 Year PerformanceN/A76.41%13.21%7.60%

Estrella Immunopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-80.8%$0.00N/A0.005Short Interest ↑
Gap Down
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.13
flat
N/AN/A$0.00$90,718.000.002Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.28
+7.7%
N/A-35.9%$0.00N/A0.0094Gap Up
APLMW
Apollomics
0 of 5 stars
$0.03
flat
N/AN/A$0.00N/A0.0059Short Interest ↑
News Coverage
Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars
$0.01
flat
N/A-76.2%$0.00N/A0.005Negative News
BCDAW
BioCardia
0 of 5 stars
$0.02
flat
N/A-98.7%$0.00$570,000.000.0030Positive News
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.37
-6.8%
N/A-41.0%$0.00N/A0.0016Positive News
Gap Up
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.13
-28.4%
N/A-78.2%$0.00$12,705.000.007Short Interest ↓
Gap Down
CTCXW
Carmell
0 of 5 stars
$0.16
-15.8%
N/AN/A$0.00$3.73M0.009Gap Down
SAVAW
Cassava Sciences
0 of 5 stars
$4.71
-10.3%
N/AN/A$0.00N/A0.0026Gap Down

Related Companies and Tools

This page (NASDAQ:ESLAW) was last updated on 3/4/2024 by MarketBeat.com Staff